Objective To study the therapeutic effect of isopsoralen on bone loss induced by simulated microgravity in mice. Methods C57BL/6J mice were randomly divided into 5 groups; ground control group(CON), tail suspension group(HU), low dose group(ISO-L), middle dose group(ISO-M)and high dose group(ISO-H), with 12 mice in each group. After 21 days of administration,all mice were sacrificed, and the five internal organs, serum, femur and tibia were taken for histopathological examination, Mirco-CT imaging analysis, serum index detection, femoral bone tissue protein analysis and alkaline phosphatase positive clone staining. Results Compared with CON group, bone mineral density(BMD)and trabecular thickness(Tb.Th)in HU group decreased significantly(P<0.01), bone volume fraction(BS/TV),bone surface area density(BV/TV%)decreased significantly(P<0.05), trabecular number(Tb.N) decreased,trabecular separation(Tb.Sp) increased; Compared with HU group, BMD, BV/TV%, Tb.Th, BS/TV increased significantly(P<0.05), Tb.N increased and Tb.Sp decreased after tail suspension administration,and the effect of high dose group was the best. Compared with CON, serum osteocalcin(OCN)in HU decreased(P<0.01), and the concentration of tartrate-resistant acid phosphatase 5b(TRACP 5b)increased(P<0.01); When isopsoralen was administered during tail suspension, OCN increased(P< 0.01)and TRACP-5 decreased(P<0.01). Compared with CON group, OPG protein expression in HU group decreased(P<0.05)and RANKL protein expression increased(P<0.05). Compared with HU group,OPG and RANKL protein expression increased and RANKL protein expression decreased(P<0.05)after isopsoralen administration. Compared with the ground control groupthe density of blue-purple alkaline phosphatase particles in HU group was lower and lighter, and the density of blue-purple alkaline phosphatase particles increased after isopsoralen was added during tail hanging. Conclusion Isopsoralen can promote bone formation and inhibit bone resorption under simulated microgravity, and effectively prevent bone loss. |